BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
7.40
-0.29 (-3.77%)
Jun 26, 2026, 4:00 PM EDT - Market closed
BBOT Market Cap
BBOT has a market cap or net worth of $592.79 million as of June 26, 2026. Its market cap has increased by 132.83% in one year.
Market Cap
592.79M
Enterprise Value
206.54M
1-Year Change
132.83%
Ranking
Category
Stock Price
$7.40
Market Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $592.79M, an increase of 1,451.31%. That is a compound annual growth rate of 216.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 592.79M | -40.81% |
| Dec 31, 2025 | 1.00B | 305.70% |
| Dec 31, 2024 | 246.84M | 545.98% |
| Feb 9, 2024 | 38.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AgomAb Therapeutics NV | 648.84M |
| SpyGlass Pharma | 648.27M |
| Ginkgo Bioworks Holdings | 637.57M |
| SL Science Holding | 631.95M |
| CorMedix | 618.20M |
| Faeth Therapeutics | 608.89M |
| 4D Molecular Therapeutics | 607.45M |
| Achieve Life Sciences | 600.04M |